These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure). Nikolaidis LA; Trumble D; Hentosz T; Doverspike A; Huerbin R; Mathier MA; Shen YT; Shannon RP Eur J Heart Fail; 2004 Jun; 6(4):409-19. PubMed ID: 15182765 [TBL] [Abstract][Full Text] [Related]
13. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867 [TBL] [Abstract][Full Text] [Related]
14. The paradox of beta-adrenergic blockade for the management of congestive heart failure. Eichhorn EJ Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791 [TBL] [Abstract][Full Text] [Related]
15. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
16. [Adrenergic betablockers and heart failure]. Lechat P Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311 [TBL] [Abstract][Full Text] [Related]
17. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure. Perez DM Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071350 [TBL] [Abstract][Full Text] [Related]
18. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)]. Sigmund M; Reineke T Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261 [TBL] [Abstract][Full Text] [Related]
19. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980 [TBL] [Abstract][Full Text] [Related]